<DOC>
	<DOCNO>NCT01582100</DOCNO>
	<brief_summary>Gastroesophageal reflux disease ( GERD ) highly prevalent condition frequently encounter health care set . It affect roughly 40 % Americans monthly 10 % weekly . Of GERD , exist cohort experience nausea without vomit unresponsive PPI 's anti-emetics . For patient , treatment option limit symptom may substantially alter quality life . New novel therapy emerge include neuromodulation device may affect central pathway lead symptom . Of , Reletex band test proven efficacious treatment nausea vomit associated pregnancy , chemotherapy , surgery , addition standard anti-nausea medication . The investigator propose similar mechanism , device adjunct PPI 's anti-emetics reduce GERD-associated nausea without vomit , , improve quality live patient population .</brief_summary>
	<brief_title>Reletex Nausea GERD Patients</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<criteria>Any patient age 18 clinically diagnose GERD evidence GerdQ assessment tool and/or ambulatory pH/ pH impedance monitoring component nausea without vomit . Continued symptom despite stable dose FDA approve daily PPI therapy addition without supportive antiemetic . We include patient twice day PPI dosing , standard treatment PPI nonresponders . Previous gastric empty study perform part standard care workup nausea vomit . Patients recruit regardless result information use potential predictor symptom response . Currently participate concurrent clinical trial complete another trial within past 8 week . Prior gastrointestinal surgery esophagus stomach . Severe esophagitis ( Los Angeles esophagitis Grade C ) , Barrett 's metaplasia eosinophilic esophagitis , achalasia spastic motor disorder Unstable medical illness ongoing diagnostic workup treatment . Patients wellcontrolled hypertension , diabetes remote history ischemic heart disease deem stable , judged physicianinvestigator include . Current drug alcohol abuse dependency . Current neurologic cognitive illness impairment would make patient unsuitable candidate hypnosis . This determined investigator randomization use Mini Mental Status Exam patient suspect impairment . Severe mental illness , e.g. , uncontrolled major depression suicidal ideation , active psychosis , diagnosis schizophreniaspectrum disorder . Those nickel , gold , metal allergy . Those neuromodulators implant electrical device cardiac pacemaker , AICD 's , neurostimulators transcutaneous electrical nerve stimulation device ( TENS unit ) . Females might become pregnant study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>